Fluxion Biosciences was formed in 2005 to address critical needs for cellular analysis tools in the pharmaceutical, biotech and research industries. The company has developed a proprietary microfluidic platform which enables precise cellular manipulation, rapid low-volume compound addition, environmental control and software-based data acquisition.
Fluxion's goal is to create innovative solutions for its customers which offer superior performance, simplified workflows and cost savings over conventional assay techniques. Fluxion's customers include:
- Biotech and pharmaceutical companies
- Leading academic institutions
- Government research organizations
384 Oyster Point Blvd. #6